About: Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kd inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3Kd inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.93 (+1.57%)
PHAR NASDAQ Pharming Group NV
Pharming Group NV share price
PHAR price activity
Last Price
$12.930
Change (24hr)
0.20 USD (1.57%)
Volume
21.56K
Volume (4w avg)
-
Open
$12.69
Day Range
$12.45 - $13.00
Previous Close
$12.73
Last Trade
03 Nov, 9:00 pm GMT+0
Delayed
03 Nov, 9:00 pm GMT+0
PHAR price performance
Delayed
03 Nov, 9:00 pm GMT+0
PHAR details
PHAR Market Signals